An activated ras oncogene induces a program of differentiation in the human medullary thyroid cancer cell line TT. This differentiation process is accompanied by a marked increase in the transcription of the human calcitonin (CT) gene. We have localized a unique Ras-responsive transcriptional element (RRE) in the CT gene promoter. DNase I protection indicates two domains of protein-DNA interaction, and each domain separately can confer Ras-mediated transcriptional inducibility. This bipartite RRE was also found to be Raf responsive. By affinity screening, we have cloned a cDNA coding for a zinc finger transcription factor (RREB-1) that binds to the distal RRE. The consensus binding site for this factor is CCCCAAACCACCCC. RREB-1 is expressed ubiquitously in human tissues outside the adult brain. Overexpression of RREB-1 protein in TT cells confers the ability to mediate increased transactivation of the CT gene promoter-reporter construct during Ras-or Raf-induced differentiation. These data suggest that RREB-1 may play a role in Ras and Raf signal transduction in medullary thyroid cancer and other cells.
Ras proteins are critical regulators of normal cell proliferation and differentiation. Activated forms of Ras are involved in a wide range of human malignancies (3, 7) . In recent years, through a remarkable convergence of biochemical assays and genetic analyses, several cytoplasmic components of the Ras signaling pathway have been elucidated (15, 17, 30, 39, 44, 49) . It is now clear that Ras proteins function as intermediates between upstream tyrosine kinases and a downstream cascade of protein kinases, including the mitogen-activated protein kinases (MAPKs) (27, 37) , the stress-activated protein kinases or the Jun kinases (SAPKs/JNKs) (59) , and the p38/HOG1 kinase (21, 43) .
While several nuclear transcription factors have been implicated as substrates of activated MAPKs and the SAPKs, the exact nuclear targets, trans-acting factors, and effectors of Rastriggered signaling still remain elusive. The best-characterized example and the first class of transcription factors shown to be activated by the Ras cascade is the AP-1 complex, a heterodimer composed of c-fos and c-jun proto-oncoproteins (47, 51, 53) . The binding site is an AP-1 motif [TGA(C/A)TCA] or, in some cases, the related CREB/ATF binding site (TGACGT CA) (22, 38, 47, 58) . Subsequently, AP-1-independent Rasresponsive elements (RREs) were identified. Some of these include a consensus binding site of GGGACTTTCCG for the NF-B families of transcription factors (2) or an Ets site in the proximal RRE region (reviewed in reference 11). The Ets family of DNA binding motif proteins recognizes a DNA sequence which includes a purine-rich core, 5Ј-GGAA-3Ј (20, 28) . Ets-related factors are known to cooperate synergistically, independent of AP-1 (56) . The only other ras-responsive factor that has been identified so far is a 120-kDa nuclear protein, RRF1, which has been found to be present in human and mouse cells (41) . RRF1 has also been found to recognize the Ets motif CAGGATATGA in the transforming growth factor-␤1 and NVL-3 enhancers and may have some relationship with the Ets family of transcription factors (42) .
Ras is known to regulate several classes of important genes. These include genes associated with the mitogenic response (e.g., c-fos and c-jun), growth factors (e.g., transforming growth factor-␤), extracellular matrix proteases (e.g., stromelysin and collagenase), and tumorigenesis and metastasis (e.g., metalloproteases, cysteine proteases, and their specific inhibitors, tissue inhibitors of metalloproteases and cystatins), and viral genes (e.g., the VL-30 element) (reviewed in references 6 and 11). Therefore, it is important to identify the downstream nuclear components, the transcription factors critical for Ras function.
While the phenotypic consequence of a constitutively activated ras pathway frequently results in increased growth and cell transformation, some cultured cell types respond to ras activation with increased cellular differentiation. These cell types include PC12 pheochromocytoma cells (36) , neuroblastoma cells (32) , lymphoblastoid cells (48) , TT human medullary thyroid cancer (MTC) cells (34) , and 3T3-L1 fibroblasts (4) . It remains unclear why the ras signaling cascade in these systems elicits cellular differentiation, instead of transformation, responses. In either event, Ras signal transduction proceeds through activation of one or more signal transduction cascades and culminates in the alteration of transcription of specific genes. We have used our tissue culture model system for human MTC, in which an activated v-ras H oncogene (34) or activation of a c-raf-1 gene (10) induces neuroendocrine differentiation, to understand the differentiation program controlled by Ras or Raf. Since a prominent feature of the differ-entiated phenotype in these cells is increased expression of the calcitonin (CT) gene (34) , we have studied the regulation of CT gene expression as a model for transcriptional regulation by Ras and Raf. Here, we describe two separate Ras-and Raf-responsive transcriptional elements (RREs) in the calcitonin gene promoter. We report the cloning of a gene for a novel zinc finger transcription factor which can specifically bind to one of the RREs of the CT gene and can augment the Ras and Raf transcriptional response of the CT gene.
MATERIALS AND METHODS
Cell culture. Culture of the TT line of human MTC cells and infection with Harvey murine sarcoma virus (HaMSV) have been described previously (34) . TT:⌬Raf-1:ER cells were cultured in phenol red-free medium, and the c-raf-1: ER gene was activated by treatment of the cells with 1 M ␤-estradiol, as described previously (10) .
Plasmid construction. For all expression studies, the plasmids discussed in detail in Results were constructed as follows. Plasmids pCT731CAT (formerly termed CT750CAT), pCT367CAT (formerly CT380CAT), pCT252CAT, and pCT132CAT, containing the indicated lengths of the CT gene 5Ј region (the numbers in these constructs reflect the lengths) as well as 88 bp of exon 1 inserted upstream from a chloramphenicol acetyltransferase (CAT) reporter gene, have been previously described (13) . pCT215CAT was derived from pCT731CAT by Bal 31 nuclease deletion. pCT252⌬14CAT was derived from pCT731CAT by Bal 31 nuclease deletion from the BamHI site at position Ϫ132 upstream to Ϫ206, followed by removal of CT gene sequences from the AatII site at position Ϫ252 to Ϫ731 by restriction with AatII and HindIII. pCT132/1-2FCAT, pCT132/ 1-2RCAT, pCT132/7-8FCAT, and pCT132/7-8RCAT were constructed by cloning oligonucleotides 1-2 and 7-8 (described below) in the forward (F) or reverse (R) orientation, upstream of the CT gene sequences in pCT132CAT. pCT132/ 1-2B and pCT132/7-8B were constructed by cloning oligonucleotides 1-2B and 7-8B in reverse orientation in the same position of pCT132CAT. All constructs were confirmed by sequencing.
Transient-transfection assays. TT cells were studied by using transient CAT expression assays 10 days after infection with HaMSV. Transfections of reporter plasmids by electroporation and assay of CAT activity (19) were done exactly as described previously (13) . For studies of raf activation of CT gene expression, uninduced TT:⌬Raf-1:ER cells were transfected with reporter plasmids by electroporation. Twenty-four hours later, cells were treated with 1 M ␤-estradiol to activate the c-raf-1:ER gene or, as a negative control, with 0.1% ethanol carrier. After a further 24 h, the cells were harvested for CAT assays.
Transient-transfection assays for RREB-1 function. The full-length RREB-1 cDNA was subcloned downstream of the long terminal repeat promoter between the XbaI and EcoRI sites of the mammalian retroviral expression vector pMV7p1 (24) . The recombinant expression plasmid is referred to as pMV7p1-371. The CAT reporter plasmids pCT132CAT and pCT252CAT have been described previously (13) , and pCT132/1-2FCAT is described above. A CAT reporter plasmid (1 or 2 g) and various amounts (2 to 4 g) of pMV7p1-371 or pMV7p1 alone were cotransfected into TT:⌬Raf-1:ER cells by using Lipofectamine (Life Technologies) according to the manufacturer's protocol. Briefly, about 10 6 cells per well were seeded in six-well tissue culture plates, 6 days prior to transfection, in 4 ml of phenol red-free RPMI-16% fetal calf serum-100 U of penicillin per ml-100 g of streptomycin per ml-200 g of G418 per ml. Twentyfour hours after Lipofectamine treatment, 4 ml of this medium was added to the wells. This medium contained either 1 M ␤-estradiol or ethanol as a carrier. All transfections were carried out in duplicate. The cells were harvested 48 h after treatment with ␤-estradiol and assayed for CAT activity as described previously (13) .
Gel mobility shift assays. Nuclear extracts were prepared from control TT cells or from TT cells 10 days after HaMSV infection according to a modification (35) of a previously described method (14) . Double-stranded oligonucleotides 1-2 (5Ј-GATCCGGTCCCCCACCATCCCCCGCCATTTCCA-3Ј), 7-8 (5Ј-ATC CATTTCCATCAATGACCTCAATGCAAATAC-3Ј), 1-2B (5Ј-GATCCGGTC CCCCACCATCCCCCGCCA-3Ј), and 7-8B (5Ј-GATCTCAATGACCTCAAT GCAAATAC) and an oligonucleotide containing a binding site for AP-1 (5Ј-G ATCAGCTTGATGATGAGTCAGCCCG-3Ј) were synthesized on an Applied Biosystems 380A DNA synthesizer, with a GATC 5Ј overhang on each strand. Double-stranded oligonucleotides containing binding sites for AP-2 (5Ј-GATC GAACTACCGCCCGCGGCCCGT-3Ј), AP-3 (5Ј-CTAGTGGGACTTTCCAC AGATC-3Ј), CREB (5Ј-GATTGGCTGACGTCAGAGAGCT-3Ј), GRE (5Ј-G ATCAGAACACAGTGTTCTCTA-3Ј), NF1/CTF (5Ј-ATTTTGGCTTGAAGC CAATATG-3Ј), NF-B (5Ј-GATCGAGGGGACTTTCCCTAGC-3Ј), OCT1 (5Ј-GATCGAATGCAAATCACTAGCT-3Ј), and Sp1 (5Ј-GATCGATCGGGG CGGGGCGATC-3Ј) were obtained from Stratagene. Oligonucleotides 1-2, 7-8, and AP-1 were 3Ј end labeled with Klenow DNA polymerase and [␣-32 P]dCTP. Gel mobility shift assays were done as previously described (35) . Approximately 1.0 ng of double-stranded oligonucleotide was bound to 3 g of TT or TTras nuclear extract at 0ЊC in 20 l of 50 mM KCl-10 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid)-5 mM EDTA-10% glycerol (pH 7.9) containing 2 g of poly(dI-dC). In those experiments using competitor oligonucleotides, the competitor was added just prior to the labeled oligonucleotide. Samples were incubated on ice for 10 min and then loaded on a 5% polyacrylamide gel and electrophoresed at 4ЊC for 2 h.
DNase I protection assay. DNase I footprinting was done according to a method previously described (25) . A restriction fragment containing CT gene sequences downstream from the DdeI site at bp Ϫ272 was 3Ј end labeled by filling in with Klenow DNA polymerase and [␣-32 P]dCTP. Binding reaction mixtures containing 10 4 cpm of end-labeled fragment, 2 g of poly(dI-dC), and 10 g of TT or TTras nuclear extract in 20 l of 25 mM Tris-HCl (pH 7.9)-6.25 mM MgCl 2 -10% glycerol-50 mM KCl were incubated on ice for 15 min and then at 22ЊC for 2 min. An equal volume of freshly diluted DNase I (4 U/ml) in 10 mM MgCl 2 -5 mM CaCl 2 was added and incubated for an additional 2 min at 22ЊC. The reaction was stopped with 40 l of 200 mM NaCl-20 mM EDTA-1% sodium dodecyl sulfate (SDS)-250 g of tRNA per ml and then phenol extracted and ethanol precipitated. Samples were run on an 8% polyacrylamide sequencing gel, with a Maxam-Gilbert G (dimethyl sulfate) reaction of the same restriction fragment as a marker.
Isolation of recombinant clones encoding RREB-1. A lambda gt11-cDNA expression library was made by random hexamer priming of poly(A) ϩ RNA from the human MTC cell line TT. A total of 200,000 plaques were screened by DNA affinity cloning (50, 55) . The catenated DNA probe of oligonucleotide (1-2) n that contained the CT gene RRE (5Ј-GATCCGGTCCCCCACCATCCCCCGCCA TTTCCA-3Ј) was labeled by nick translation with [␣-32 P]dCTP, and 10 6 cpm/ml was used for the binding reaction. During secondary and tertiary screening of the expression library, 100 mg of sonicated calf thymus DNA (sheared to ca. 1 kb, heat denatured 10 min at 99ЊC, and quenched on ice) was used as a nonspecific competitor in a 50-ml binding reaction mixture with the labeled catenated DNA probe. Filter lifts, binding reactions, and washes were carried out on the same day. A positive clone termed lambda gt11-24.1 was picked for further characterization. This 2.16-kb partial cDNA was subcloned after PCR amplification of the lambda gt11-24.1 recombinant by using lambda gt11 primers (GT1 and GT2; New England Biolabs).
To obtain the full-length cDNA, we screened the gt11 TT cDNA library with the 2.16-kb cDNA. We subsequently screened this library and an SW480 colon cancer cell library (Clontech) with probes for the most 5Ј cDNA clone. Filters were hybridized at 60ЊC overnight in BLOTTO (5ϫ SSPE [1ϫ SSPE is 0.18 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA {pH 7.7}], 10% formamide, 1.0% SDS, 6.0% polyethylene glycol 6000, 200 g of salmon sperm DNA per ml, 5.0 mg of powdered milk per ml), washed sequentially in 2ϫ SSC (1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% SDS at room temperature for 10 min and in 0.1ϫ SSC-0.5% SDS at 65ЊC for 20 min, and exposed to film at Ϫ70ЊC. Following EcoRI digestion of the recombinant phage DNA, the cDNAs were subcloned directly into pBluescript. Nucleotide sequences were determined by double-stranded DNA sequencing by the chain termination method (Sequenase 2.0; United States Biochemicals). All cDNA clones were confirmed to be nonchimeric by reverse transcription-PCR on RNA from TT cells or Caco2 cells, using an anchored primer within confirmed sequences and a paired primer from the most 5Ј clone. Comparisons were made with existing nucleotide and amino acid sequences from GenBank/EMBL by Blast searching.
DNA-protein binding assays. (i) DNA binding specificity. The lambda gt11-24.1 recombinant clone (containing the three C-terminal zinc fingers of RREB-1) was plated at a density of about 250 plaques per 15-mm-diameter petri dish with top agarose containing 10 mM IPTG (isopropyl-␤-D-thiogalactopyranoside). After plaque formation, a nitrocellulose filter (BAS; Schleicher & Schuell) was overlaid on this dish for 4 h at 37ЊC. The filter was cut into three equal parts and was subjected to the DNA binding assay (50, 55) in three separate petri plates. One of the triplicates was incubated with the oligonucleotide (1-2) n catenated probe (actual binding site probe), the second was incubated with the oligonucleotide (7-8) n probe (a downstream region of the CT promoter), and the third was incubated with a catenated oligonucleotide (5-6) n probe (a randomer, similar in size and base composition to oligonucleotide 1-2). The binding reactions were carried out in the presence of the calf thymus DNA, and the filters were processed and washed as described above under library screening and exposed to film.
(ii) Southwestern (DNA-protein) blot analysis. Bacterially produced glutathione S-transferase (GST)-RREB-1 fusion protein, TT nuclear extract, and GST protein alone were electrophoresed on an SDS-polyacrylamide gel and transferred to a nitrocellulose filter. This filter was probed for sequence-specific DNA binding activity (33) . A catenated oligonucleotide (1-2) n probe was prepared as described above under library screening. Sonicated salmon sperm DNA was used as a nonspecific competitor. The filters were blocked with 5% (wt/vol) nonfat dry milk in binding buffer (10 mM HEPES [pH 7.9], 50 mM KCl, 1 mM EDTA, 1 mM dithiothreitol) for 1 h at 4ЊC, transferred to binding buffer supplemented with 0.25% dry milk and 10 5 cpm of ␣-32 P-labeled DNA probe per ml, and incubated for another hour at 4ЊC. Filters were washed in three 100-ml changes of binding buffer-0.25% dry milk at 4ЊC, blotted on 3 MM Whatman paper, and exposed to film at Ϫ70ЊC.
(iii) Gel mobility shift assays. Mutant oligonucleotides with various base substitutions in the wild-type oligonucleotide 1-2 (see Fig. 5a ) were purchased from Life Technologies. Oligonucleotides were made double stranded with the appropriate reverse primer (R1 [5Ј-TGGAAATGG-3Ј] or R2 [5Ј-TGGAAAGT 5336 THIAGALINGAM ET AL. MOL. CELL. BIOL.
CA-3Ј]) and Klenow DNA polymerase and labeled with [␣-32 P]dCTP. Gel mobility shift assays were done as previously described (35) with 3 g of TT nuclear extract or 500 ng of purified GST-RREB-1.
Northern (RNA) blot analysis. Total RNA was extracted from the TT and TTras cells by the acid phenol-guanidium isothiocyanate method (12) . Cell culture and virus infection were as previously described (34) . Ten g of poly(A) ϩ RNA from TT or TTras cells was electrophoresed on a 1.5% formaldehyde gel, transferred to Zetaprobe filters, and hybridized by using a nick-translated 2.16-kb fragment of the RREB-1 cDNA. The blot was rehybridized to a human ␤-actin cDNA probe as a control for loading. Hybridization signals were quantitated with a PhosphorImager (Molecular Dynamics) and analyzed with ImageQuant software. A Northern blot containing 2 g of poly(A) ϩ RNA from various adult human tissues was purchased from Clontech and hybridized to a 1.4-kb cDNA of RREB-1 labeled with [␣-32 P]dCTP by nick translation. Binding site selection. Affinity-purified GST-RREB-1 fusion protein was used to isolate binding sites from a degenerate oligonucleotide, according to a modified CASTing (cyclic amplification and selection of target sequences) method (40, 57) . The degenerate oligonucleotide consisted of a 60-mer beginning with the sequence 5Ј-GAGATATTAGAATTCTACTC followed by a stretch of 23 random bases and ending with the sequence 5Ј-GGTACATATACTCGAGT. Underlined are the EcoRI and XhoI sites designed in the 60-mer to facilitate subcloning of the selected fragments.
The oligonucleotide was made double stranded by hybridization with primer LL-XhoI-A (5Ј-TGCACTCGAGTATATGTACC-3Ј) and elongation for 30 min at 30ЊC with Klenow DNA polymerase. This double-stranded oligonucleotide (0.25 g) was bound to 5 g of the dialyzed fusion protein in 100 l of buffer [20 mM HEPES, 40 mM KCl, 2 g of poly(dI-dC), 2 mM MgCl 2 , 0.1 mM ZnSO 4 , 1 mM dithiothreitol, 5% glycerol, 0.2 mg of bovine serum albumin (BSA) per ml]. The protein-DNA complexes were bound to a 50% slurry of glutathione-Sepharose, equilibrated in low-salt buffer (50 mM Tris [pH 8.0], 10 mM EDTA, 0.2 mg of BSA per ml, 0.1% Nonidet P-40), and washed twice with low-salt buffer and twice with low-salt buffer lacking Nonidet P-40. The specific DNA was eluted by four successive rounds of heating at 100ЊC for 2 min in high-salt buffer (1 M NaCl, 50 mM Tris [pH 8.0], 10 mM EDTA) and ethanol precipitated. The pellet was resuspended in LTE (10 mM Tris [pH 7.5], 1 mM EDTA), and PCR was performed with primers LL-EcoRI-A and LL-XhoI-A (29) in a 50-l reaction volume containing 200 M each deoxynucleoside triphosphate and 100 Ci of [␣-
32 P]dCTP. The PCR was hot started at 94ЊC for 5 min, Taq DNA polymerase (Boehringer Mannheim) was added, and cycles were at 95ЊC for 30 s and 60ЊC for 30 s for 30 cycles with a final extension at 72ЊC for 5 min. The PCR product was purified on a TE-30 column (Clontech). The amplified oligonucleotides were subjected to four additional cycles of binding, selection, amplification, and purification. GST protein was used as a negative control for the same kind of selection and amplification. The selected fragments were digested with EcoRI and XhoI, gel purified, and cloned into pBluescript (Stratagene). Individual clones were isolated and sequenced. To confirm the specificity of selected binding site clones, a gel mobility shift assay was performed exactly as above.
Nucleotide sequence accession number. The GenBank accession number for RREB-1 is U26914.
RESULTS
Localizing an RRE in the CT gene promoter. The stimulation of CT gene transcription in TT cells by v-ras H in our earlier studies (34) prompted us to search for an RRE. The human CT gene 5Ј sequences, from position Ϫ731 to ϩ88, were placed upstream of the CAT reporter gene. This construct and constructs with deletions within the upstream calcitonin gene sequences were tested for expression and ras inducibility by electroporation into uninfected TT cells and into TT cells infected with HaMSV (TTras cells). A summary of the results obtained from these experiments is outlined in Fig. 1a and b. Introduction of v-ras H stimulated expression from constructs containing at least 215 bp of calcitonin gene 5Ј sequences but not from the construct containing 132 bp. Deletion of sequences from position Ϫ206 to Ϫ132 from a ras-inducible construct (pCT252CAT) which contained 252 bp of the 5Ј sequences of the CT gene rendered the resultant construct (pCT252⌬14CAT) refractory to ras induction (Fig. 1a) . Therefore, an RRE in the calcitonin gene appears to reside within the sequences from position Ϫ215 to Ϫ132.
To further delineate and characterize the sequences responsible for RRE function in the human CT gene, we first looked for known transcription factor binding motifs within the region from position Ϫ215 to Ϫ132 (Fig. 1c) . Within this sequence, a sequence related to a TPA-responsive element (TRE) from position Ϫ168 to Ϫ161 and an octamer sequence from position Ϫ161 to Ϫ154 have been noted (8) . In addition, we noted a direct decamer repeat, TCCCCCPuCCA, from position Ϫ199 to Ϫ180 and an imperfect 27-base palindrome, which includes two putative octamers similar to homeodomain binding sequences, from position Ϫ180 to Ϫ154. A sequence comparison of the 5Ј region (position Ϫ300 to Ϫ60) of the human CT gene with that of the rat gene revealed a high level of conservation, suggesting important functional regulatory roles.
Defining the RRE. Within the upstream human CT gene candidate RRE region, DNase I footprinting with nuclear extracts from TT or TTras cells showed two areas of partial protection (Fig. 2a) . One of these areas, from position Ϫ199 to Ϫ180, included the decamer repeat, and the other, from about position Ϫ175 to Ϫ110, included the 27-base palindrome, the putative TRE, and the octamer sequences. No differences in protection between the patterns resulting from the use of TT or TTras nuclear extract were apparent.
These protected sequences were examined further by gel mobility shift assays. Double-stranded oligonucleotides corresponding to each of the above-described partially protected areas were synthesized. Oligonucleotide 1-2, containing the C-rich decamer repeat, extended from base Ϫ201 to base Ϫ174, and oligonucleotide 7-8, containing the 27-base palindrome, extended from base Ϫ182 to base Ϫ152 (Fig. 1c) . The interaction of these oligonucleotides with either a TT or TTras cell nuclear extract resulted in the formation of specific DNAprotein complexes for each of the sequences analyzed (Fig.  2b) . The DNase I protection assay as well as the gel mobility shift assay showed no apparent differences between TT and TTras nuclear extracts, indicating the potential involvement of a similar factor(s) in the assembly of these nuclear protein complexes.
Two distinct complexes bind the RRE. At least some of the proteins responsible for the complexes formed with oligonucleotides 1-2 and 7-8 are unique. The complexes formed with oligonucleotide 1-2 are not efficiently inhibited by competition with excess oligonucleotide 7-8 (Fig. 2b, panel A, lane 5) . Moreover, the complexes formed with oligonucleotide 1-2 are very sensitive to the sulfhydryl blocker methylmethane thiosulfonate, while those formed with oligonucleotide 7-8 are relatively insensitive to this agent (data not shown), further suggesting that these complexes are not identical. However, complexes formed by oligonucleotide 7-8 are inhibited by oligonucleotide 1-2 (Fig. 2b, panel B, lane 4) , suggesting that some of the proteins involved in binding of these two oligonucleotides may be shared.
We have previously shown that TTras cells exhibit induced expression of c-jun and contain proteins which will bind to a AP-1/Jun consensus sequence (35) . Since oligonucleotide 7-8 contains sequences related to the AP-1 consensus binding site, we examined the possibility that AP-1/Jun might be involved in binding to oligonucleotide 7-8. An oligonucleotide containing a consensus sequence for AP-1/Jun failed to effectively compete for binding to oligonucleotide 1-2 or 7-8 (Fig. 2b, lanes 6 ). These data indicate that the protein complexes binding to oligonucleotides 1-2 and 7-8 are distinct from the AP-1 family.
The protein complexes formed with oligonucleotides 1-2 and 7-8 also do not appear to be related to transcription factor AP-2, AP-3, NF1/CTF, or Sp1. To demonstrate this, we attempted to inhibit the binding of oligonucleotide 1-2 or 7-8 by competition with excess oligonucleotides containing a consensus sequence for these transcription factors. In addition, protein complex formation with oligonucleotide 1-2 was also tested for competition with excess oligonucleotides containing consensus sequence for transcription factors CREB, GRE, VOL. 16, 1996 AN RRE AND ITS BINDING FACTOR, RREB-1 5337 VOL. 16, 1996 AN RRE AND ITS BINDING FACTOR, RREB-1 5339
on February 20, 2013 by PENN STATE UNIV http://mcb.asm.org/ NF-B, and OCT1. None of these consensus sequence oligonucleotides were able to inhibit the binding to either oligonucleotide 1-2 or 7-8 (Fig. 2c) . The CT gene RRE is bipartite. We examined whether the domains of the CT gene represented by oligonucleotides 1-2 and 7-8 can function separately in ras-mediated enhancement of CT gene transcription. Oligonucleotides 1-2 and 7-8 were separately cloned into the ras-noninducible construct pCT132CAT, which contains 132 bp of CT gene 5Ј sequences but not the RRE. Each of these oligonucleotides, in either orientation (forward [F] or reverse [R]), rendered the pCT132CAT construct ras inducible (Fig. 1a and b) . These results suggested that the RRE is bipartite and that either domain can independently confer Ras responsiveness. However, since oligonucleotides 1-2 and 7-8 contain nine overlapping bases, it was still possible that the shared nucleotides constituted a single RRE. To test this possibility, we cloned the truncated oligonucleotides 1-2B and 7-8B, from which these nine overlapping bases were removed, into pCT132CAT. These constructs were also Ras responsive (data not shown), indicating that the two domains in the CT gene RRE can function independently. One possible reason for the large variation in these CAT assays and hence the large error bars could be variable expression of v-ras H , since a new HaMSV infection was necessary for each experiment. Therefore, we examined an inducible system for TT cell differentiation, employing an activatable c-raf-1 gene, as described below.
We have recently shown that the differentiation program induced by v-ras H in TT cells can also be induced by activation of c-raf-1 (10), which acts downstream of ras in many cell systems. A retroviral construct encoding an activated c-Raf-1 protein fused to the hormone binding domain of the estrogen receptor (⌬Raf-1:ER) (46) was introduced into the TT cell line. In these cells (TT:⌬Raf-1:ER), c-raf-1 can be activated by 1 M estradiol. Upon addition of estradiol, the cells cease proliferation and manifest the same changes in morphology and changes in CT gene expression as seen in the v-ras H insertion studies. In the current study, we have transfected these rafinducible TT cells with pCT132CAT, as well as pCT132CAT constructs additionally containing oligonucleotides 1-2 and 7-8. The activation of c-raf-1 enhanced the activity of the CAT constructs with oligonucleotide 1-2 or 7-8, indicating that these RREs are also Raf responsive (Fig. 1a and b) .
Cloning of RREB-1, a zinc finger protein. DNA affinity cloning was utilized to isolate a cDNA clone for a protein, RREB-1, with DNA binding specificity for the RRE represented by oligonucleotide 1-2. By screening 200,000 primary plaques of a TT cell cDNA library in lambda gt11, we initially isolated one cDNA clone which encoded a DNA binding domain specific for oligonucleotide 1-2. Overlapping clones were isolated, by hybridization, from this library and a cDNA library made from a colon cancer cell line SW480. The complete coding sequence predicts a protein of 755 amino acids (89 kDa), with four tandem, C 2 H 2 -type zinc fingers (Fig. 3) . RREB-1 does not exhibit any striking homologies, except for the zinc finger domains, to other genes or proteins, as determined by Blast and Prosite searches. Several putative phosphorylation sites were identified by comparing the amino acid residues with known phosphorylation sites. This included one (PESP) for MAPK (1) near the predicted C terminus of RREB-1.
DNA binding characteristics of RREB-1. A DNA binding assay was performed in order to confirm and further define the sequence specificity of RREB-1, and a Southwestern blot analysis and a gel shift assay were performed to confirm binding of RREB-1 to its cognate oligonucleotide, 1-2. For the DNA binding assay, the plaque lift assay originally used to isolate RREB-1 was repeated on a confluently lysed plate of phage lambda gt11-24.1 (producing the ␤-galactosidase-RREB-1 fusion protein containing the zinc finger domains II, III, and IV [numbering of the finger domains is from N to C terminal]). This assay showed that the ␤-galactosidase-24.1 fusion protein bound strongly to oligonucleotide 1-2 but not to oligonucleotide 7-8 or to a randomer, oligonucleotide 5-6 (Fig. 4a) . The GST-RREB-1 fusion protein (GST-24.1) showed binding to oligonucleotide 1-2 in Southwestern blotting and gel mobility shift assays (Fig. 4b and c) . Taken together, these data are consistent with a role for this protein as a sequence-specific DNA-binding protein.
To examine whether RREB-1 corresponds to any of the DNA binding activities detected in the cell extracts, and also to define the nucleotides within oligonucleotide 1-2 that are critical for RREB-1 protein association, the relative affinities of the cellular protein and the recombinant protein for a set of oligonucleotides related to oligonucleotide 1-2 but mutated in specific bases (Fig. 5a) were tested. As shown in Fig. 5b , the protein-DNA complexes formed with the mutant oligonucleotides had migration patterns different from that of the complexes formed with oligonucleotide 1-2. The recombinant protein, GST-RREB-1, showed no binding to the mutant oligonucleotides M1, M2, M3, M4, and M5 (Fig. 5b) . These data indicate that the pattern of DNA binding specificity shown by RREB-1 is consistent with that seen for binding of oligonucleotide 1-2 in TT cell nuclear extracts.
Expression of RREB-1 mRNA in cells and tissues. The expression of RREB-1 in TT cells and TTras cells and in a variety of normal human tissues was evaluated by Northern blot analysis (Fig. 6) . A 9.0-kb mRNA transcript was observed in both cell lines and in all tissues, with the exception of adult brain. The levels of RREB-1 mRNA in these tissues appeared to be similar. During ras-induced differentiation, steady-state expression of RREB-1 mRNA appeared to be increased twofold, raising the possibility that RREB-1 expression may be regulated in part at the mRNA level by Ras.
A consensus binding site for RREB-1. The consensus binding sequence for RREB-1 was determined by CASTing (57) . DNA sequences which could bind tightly to RREB-1 were selected by five rounds of binding of random DNA sequences to GST-RREB-1 followed by PCR amplification (see Materials and Methods). The final pool of selected DNA sequences was cloned in pBluescript and sequenced. The RREB-1 bind- This sequence is closely related to the sequence CCCCACCATCCCC, found within the CT gene RRE. A bias toward C and A is also seen in the bases flanking this 14-base core consensus site (Fig. 7a) , suggesting that the consensus may be a 9-to 11-base repeat. This would be similar to the 10-bp repeat seen in the CT gene RRE. Such a repeating pattern might suggest that two molecules of RREB-1 are necessary for strong binding to this sequence, and it would be consistent with the results of the gel shift experiments described above (Fig. 5) , in which mutation of bases in either repeat within oligonucleotide 1-2 interfered with binding.
The individual binding sequences of selected clones were confirmed by gel mobility shift assay to form specific DNAprotein complexes with the TT nuclear extracts (Fig. 7b) . Included in this assay as a negative control was a fragment selected by CASTing with the GST protein alone (GGTACA TATTTCGAGTCGATGA), and the CT gene RRE oligonucleotides 1-2 (a 33-mer) and dsAT1 (a 60-mer containing the sequence of oligonucleotide 1-2, described in Materials and Methods) were included as positive controls. Oligonucleotide 1-2 produced three major protein-DNA complexes with the TT nuclear extract. A protein-DNA complex with a mobility similar to that of the most slowly migrating protein-DNA complex was present in all of the CASTing-selected binding site clones and the dsAT1 positive control fragment, but this specific protein-DNA complex was not seen with the fragment selected with GST protein alone. Thus, the RREB-1 consensus binding site is similar to the motif found in the CT gene RRE, and similar binding activity is present in TT cell nuclear extracts.
Transcriptional activation of the CT gene by RREB-1. The ability of RREB-1 to directly activate gene expression through its DNA binding site in the CT gene was tested with the TT: ⌬Raf-1:ER cells. These TT cells, which stably express ⌬Raf-1: ER, are morphologically identical to parent TT cells. However, when exposed to estradiol, activation of ⌬Raf-1:ER rapidly induces a differentiation response identical to that seen following infection of TT cells with v-ras H , including activation of CT gene expression (10) . Since TT:⌬Raf-1:ER cells provide an inducible system in which differentiation can be easily manipulated, we chose to examine RREB-1 function in these cells. Reporter plasmid pCT132CAT (lacking the RRE), pCT252CAT (containing both of the RREs), or pCT132/1-2FCAT (containing only the distal RRE) and a Moloney murine leukemia virus long terminal repeat-driven eukaryotic expression vector encoding RREB-1 were cotransfected into TT:⌬Raf-1:ER cells. These cells then either were left untreated or were treated with estradiol to activate the Raf:ER protein kinase. Cotransfection of pCT252CAT, containing both RREs, with the RREB-1 expression plasmid resulted in a threefold increase in the reporter gene expression upon ␤-estradiol treatment compared with the cotransfection of the pCT252CAT reporter gene with the expression vector alone (Fig. 8) . Cotransfection of pCT132/ 1-2FCAT, containing the distal RRE, with the RREB-1 expression plasmid increased inducible CAT activity by fivefold in the reporter gene expression upon ␤-estradiol treatment . A nitrocellulose replica filter was prepared from plating the ␤-galactosidase fusion protein specified by the bacteriophage lambda gt11-24.1 recombinant. This filter was cut into three equal parts and probed with oligonucleotide 1-2, 7-8, or 5-6 (randomer sequence) in the presence or absence of calf thymus DNA as a nonspecific competitor. All probes were labeled to the same specific activity, and each was used at a concentration of 10 6 cpm/ml. Shown are the blots probed in the presence of the calf thymus DNA. (b) Southwestern blot analysis of the protein specified by bacteriophage lambda gt11-24.1 cloned into the pGEX3 plasmid in order to produce a GST fusion protein, GST-24.1, upon induction with IPTG. Bacterial cell (Topp 2 cells; Stratagene) extracts, purified GST fusion protein, and TT nuclear extract were electrophoresed on an SDS-10% polyacrylamide gel and transferred to a nitrocellulose membrane as described in Materials and Methods. (Fig. 8) . No difference in gene expression was observed for untreated TT:⌬Raf-1:ER cells cotransfected with pCT252CAT and RREB-1 or with pCT132/1-2FCAT and RREB-1. Expression of pCT132CAT, lacking the RRE, was not augmented by cotransfection of RREB-1 into TT⌬Raf-1:ER cells, even upon estradiol treatment. These cotransfection experiments showed that RREB-1 activated the expression of the CAT reporter gene adjacent to its cognate binding site (RRE), and this activation was Raf dependent. In addition, these results indicate that RREB-1 cannot activate gene expression from other sequences within the 132-bp basal CT promoter.
DISCUSSION
The ability of a mutated ras gene to differentiate TT cells in culture affords an excellent in vitro model to dissect the transcriptional components of the Ras intracellular signaling cascade and also to identify the gene(s) which may be involved in the normal differentiation of the thyroid C-cells, the progenitor cells of MTC. Our data show that in vitro protein-DNA binding to CT gene RRE sequences is unchanged by an activated v-ras H gene. Several known transcription factors bind DNA equally well under basal or induced conditions. Induction of transcription via these factors depends on phosphorylation. These transcription factors include yeast heat shock factor (52) , cyclic AMP responsive element-binding protein (CREB) (18), Oct-2 (54), and Sp1 (23) . Similarly, transcriptional activation from the CT gene RRE may also require phosphorylation or other posttranscriptional modification of the proteins involved in the binding to oligonucleotides 1-2 and 7-8.
Three parallel pathways of protein kinase cascades, activated by Ras, have been described. In these three pathways, the signal is propagated by the sequential activation of Raf, MEK, and MAPK families of protein kinases; of MEKK, SEK/ MKK-4, and JNK protein kinases; and of p38/HOG1 protein kinases, respectively. RREs in a number of other genes have been described previously. In many of these genes, the RREs appear to be related to consensus binding sequences for AP-1, Ets-, or NF-B-related transcription factors. The activation of some of these transcription factors is dependent on phosphorylation by ras-activated protein kinases (26) . For example, cJun is phosphorylated by JNK protein kinases, and this stimulates its activity as part of the AP-1 complex. Similarly, the Ets family member Elk-1 can be phosphorylated by MAPKs, thereby stimulating its activity as part of the ternary complex which activates the c-fos promoter. Finally, either c-Raf-1 or JNK can phosphorylate the NF-B inhibitor protein IB, resulting in the release and nuclear translocation of active NF-B (9).
The fact that CT gene transcription is responsive not only to activated ras but also to activated raf suggests that Ras may stimulate the CT gene through the Raf-MEK-MAPK pathway. Further evidence for this hypothesis is derived from the observation that RREB-1 is able to augment the Raf-mediated transcriptional response of the CT promoter. These observations together suggest that RREB-1 may be activated through phosphorylation by a MAPK, although it is possible that crosstalk among signal transduction pathways could be operative in this system. Furthermore, within the predicted amino acid sequence of RREB-1, we have identified a candidate site for phosphorylation by MAPK. Several reported RREs are bipartite, having at least two motifs for binding of transcription factors, and have been shown to require both domains for RRE function, suggesting that synergistic effects of the transcription factors are necessary (16) . We have shown that the CT gene RRE is bipartite; however, its function can be mediated independently by either of the two DNA binding motifs we have identified. This suggests that each of the bound transcription factors in the CT gene RRE can independently mediate a transcriptional signal, without the synergistic interaction of a second factor. The biological significance of a bipartite RRE in the CT gene, in which each domain can function independently, is unclear. However, one could imagine, for example, that the two domains act synergistically in vivo, although in our transientexpression assays in vitro, such synergy was not evident. Alternatively, the transcription factors which interact with these two domains may be activated separately by different types of stimuli. These stimuli might induce different programs of cell response, each of which might mediate increases in CT gene transcription.
In cultured MTC cells, Ras induces a program of neuroendocrine differentiation (34) . In vivo, human MTC tumors also were picked and analyzed in a gel mobility shift assay with TT nuclear extract. Included in this assay were oligonucleotide 1-2 and dsAT1 as positive controls. dsAT1 is a 60-mer synthesized with the oligonucleotide 1-2 sequence surrounded by bases corresponding to the flanking sequences of the degenerate oligonucleotide used in CASTing. A randomly picked clone isolated by CASTing with GST alone was also included in this assay (described in Results). The arrowhead indicates a specific DNAprotein complex present in all the clones selected with GST-RREB-1 by CASTing and in the two positive controls (lanes 2 and 8) but absent in the clone selected with GST alone (lane 7).
VOL. 16, 1996 AN RRE AND ITS BINDING FACTOR, RREB-1 5343 display a phenotype which suggests that maintenance of neuroendocrine differentiation may be important in the course of the disease. Usually, these tumors are slowly growing and well differentiated, marked by homogeneously high levels of calcitonin by immunohistochemistry. However, in occasional MTC patients, calcitonin immunohistochemical staining may be heterogeneous or absent. This latter subset of MTC is frequently accompanied by rapid tumor growth and a poor prognosis (5, 31, 45) . One may speculate that disruption of the biochemical pathways influenced by Ras in TT cells, including the factor(s) interacting with the RRE reported here, may be involved in the tumor progression observed in vivo. The functional roles of RREB-1 and other transcription factors which interact with the RRE elements defined in this study will be important not only for understanding basic aspects of transcriptional regulation of the CT gene but also for understanding the differentiation behavior of C-cells and MTC.
